Skip to Content
Stephen Y Nakada, MD, FACS

Contact Dr. Nakada

E-mail:
nakada@urology.wisc.edu

Phone:
(608) 263-1359

Mail:
UW Medical Foundation Centennial Building
1685 Highland Ave
MADISON, WI 53705-2281

Stephen Y Nakada, MD, FACS

Chairman, Department of Urology
The David T. Uehling Chair of Urology

Education

  • MD, University of Rochester School of Medicine and Dentistry, Rochester, NY, 1988
  • Internship and Residency, Strong Memorial Hospital, University of Rochester, Rochester, NY, 1989-1994
  • Fellowship, Endourology and Stone Disease, Barnes Hospital, Washington University, St. Louis, MO, 1994-1995

Clinical Specialties

Dr. Nakada is certified by the American Board of Urology. He is an internationally renowned expert in urinary stones disease (urolithiasis) and minimally invasive urology. In 1997, he performed and reported the first hand-assisted laparoscopic nephrectomy, in the United States, using a sleeve. In 2001, he was named Chairman of Urology and the first David T. Uehling Chair and Professor of Urology.

In 2003, Dr. Nakada became the 15th Dornier/A.F.U.D. Award Winner for Innovative Research in Urology. He was the 2004 recipient of the Gold Cystoscope Award from the American Urological Association. Dr. Nakada has served on both the Staghorn Stone Guidelines Committee and the Distal Stones Guidelines Panel of the American Urological Association. He is listed in Best Doctors in America, Castle Connelly’s Top Doctors, and Madison Magazine’s Top Docs.

Dr. Nakada has authored or coauthored more than 200 scientific articles and 50 book chapters, and he has edited seven textbooks. He has served on the ABU/AUA Examination Committee as well as editorial boards for Urology, the Journal of Endourology and Urology Times. Dr. Nakada is the Secretary General of the Endourology Society and he is currently a member of the AUA Board of Directors, the American Association of Genitourinary Surgeons, and the Clinical Society of Genitourinary Surgeons, among other societies. Dr. Nakada is also a Trustee of the American Board of Urology.

Research Interests

Dr. Nakada’s research focuses on pathophysiology of the ureter and all aspects of urinary stone disease. His research is currently supported by the American Urologic Association.

Recent Publications
  • Grimes MD, Blute ML, Wittmann TA, Mann MA, Zorn K, Downs TM, Shi F, Jarrard DF, Best SL, Richards KA, Nakada SY, Abel EJ. A Critical Analysis of Perioperative Outcomes in Morbidly Obese Patients Following Renal Mass Surgery. Urology 2016 Jun 20.
    [PubMed ID: 27339026]
    More Information
  • Penniston KL, Wertheim ML, Nakada SY, Jhagroo RA. Factors associated with patient recall of individualized dietary recommendations for kidney stone prevention. Eur J Clin Nutr 2016 May 25.
    [PubMed ID: 27222155]
    More Information
  • Penniston KL, Sninsky BC, Nakada SY. Preliminary Evidence of Decreased Disease-Specific Health-Related Quality of Life in Asymptomatic Stone Patients. J. Endourol. 2016 May; 30 Suppl 1():S42-5.
    [PubMed ID: 26864746]
    More Information
  • Streeper NM, Nakada SY, Wertheim ML, Best SL. Preliminary Evidence Suggests Periureteral Botulinum Toxin Type A Injection Improves Ureteral Stone Passage in the Porcine Model. J. Endourol. 2016 Mar; 30(3):327-31.
    [PubMed ID: 26560963]
    More Information
  • Lloyd GL, Lim A, Hamoui N, Nakada SY, Kielb SJ. The Use of Medical Expulsive Therapy During Pregnancy: A Worldwide Perspective Among Experts. J. Endourol. 2016 Mar; 30(3):354-8.
    [PubMed ID: 26482104]
    More Information
  • Penniston KL, Nakada SY. Treatment expectations and health-related quality of life in stone formers. Curr Opin Urol 2016 Jan; 26(1):50-5.
    [PubMed ID: 26626885]
    More Information
  • Streeper NM, Nakada SY. Author reply. Urology 2016 Jan; 87():38-9.
    [PubMed ID: 27243083]
    More Information
  • Preminger GM, Bell JR, Nakada SY. Medical Expulsive Therapy is Useful for Urinary Calculi. J. Urol. 2016 Mar; 195(3):554-6.
    [PubMed ID: 26690572]
    More Information
  • Blute ML, Zorn K, Grimes M, Shi F, Downs TM, Jarrard DF, Best SL, Richards K, Nakada SY, Abel EJ. Extreme Obesity Does Not Predict Poor Cancer Outcomes Following Surgery for Renal Cell Cancer. BJU Int. 2015 Nov 21.
    [PubMed ID: 26589741]
    More Information
  • Streeper NM, Radtke AC, Penniston KL, McDermott JC, Nakada SY. Percutaneous Nephrolithotomy in Patients With BMI >50: Single Surgeon Outcomes and Feasibility. Urology 2016 Jan; 87():33-9.
    [PubMed ID: 26456745]
    More Information


webmaster@surgery.wisc.edu Copyright © 2016 The Board of Regents of the University of Wisconsin System